Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.
about
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profileInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueIntegrating Interleukin-6 into depression diagnosis and treatmentNeuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disordersImmune and Neuroendocrine Mechanisms of Stress Vulnerability and ResilienceSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant usersBiomarkers for depression: recent insights, current challenges and future prospects.Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression.Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.Depression in silent lacunar infarction: a cross-sectional study of its association with location of silent lacunar infarction and vascular risk factors.Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA)Cytokine variations and mood disorders: influence of social stressors and social support.Lipid peroxidation and depressed mood in community-dwelling older men and women.C-reactive protein gene variants: independent association with late-life depression and circulating protein levelsPatients with blepharitis are at elevated risk of anxiety and depressionDepression sum-scores don't add up: why analyzing specific depression symptoms is essentialAssociation between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing Hematopoietic stem cell transplantation.Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive EpisodesSex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaStress is a principal factor that promotes tobacco use in femalesPathogenesis of depression: Insights from human and rodent studies.Stressful early life experiences and immune dysregulation across the lifespanA dialogue between the immune system and brain, spoken in the language of serotonin.Anxiety disorders and inflammation in a large adult cohortHigh-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.The association between immune activation and manic symptoms in patients with a depressive disorder.Serum proteomic profiling of major depressive disorder.Cytokine production capacity in depression and anxiety.Chronobiology of mood disorders.Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?Cellular aging in depression: Permanent imprint or reversible process?: An overview of the current evidence, mechanistic pathways, and targets for interventions.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.
P2860
Q21245293-84EA6569-FB46-414B-A8C3-F2250BD77751Q26749497-78EC7BDE-1E1A-4034-84E2-58C34101DCE2Q26827833-B77DB890-0354-411F-9C63-771C793286DEQ28070891-D0BEA93D-0AF6-4111-919C-2D3BBB35FDECQ28080344-CB4D9AA6-69D0-4625-B376-9E03FACE6974Q28080546-AD943389-02F9-47C6-80E4-85FACC163FDDQ28390537-CA43FBA0-B418-4CA1-872A-F36DAB8F3280Q28396103-F3382CC8-6E91-4B3F-86F4-ECAFF5DC65A1Q33604879-F59E1431-B51C-4693-92CE-BF2B64A3B4A2Q33620656-3C0A88A3-5830-41CB-80B9-053B17A39BA4Q33704099-2E43EB6B-0038-4649-8A8F-E74D60DF858EQ33714240-31E0DDBC-6FA5-4FF6-854D-03E45CFCDE88Q34000520-AE5AEE06-E5DB-4CCA-9D74-437E3C42C6C7Q34250610-33CD99C0-2D25-467B-999B-5877E5BE6177Q34384181-8CA57F22-35EC-4FA3-A5DF-54187FD91E5CQ34526470-BDF6247C-6427-4992-B9E7-88B1FCF44A9BQ34603386-1596E1B4-04E2-433C-8E83-FEFD269289D7Q34708116-A29C63CC-9217-448D-9833-7E15CF9034EDQ34775703-530985D4-B361-4BB6-8716-BBDB5A4CFE61Q35034809-07573D17-C2D0-41FA-93CA-D98D9DC645C9Q35080294-7ECC48FC-E178-4A2F-B366-BEC242DBAEBCQ35276531-253053B9-FCA8-4402-AFFD-B45B057C6660Q35540027-AA075DA7-5D0B-4D11-8E08-84F27C5C6BB6Q35554351-C2457F22-B0AB-4A7A-920D-01EEAF6BB839Q35701966-C2D76B87-ABAB-458F-86DF-6F04F170303BQ36032426-C40FF985-1C6E-4203-9E67-490C7CF6DE9FQ36063627-5792AB56-F064-400B-874E-C559E4176B80Q36200563-35E5FBF0-87DA-4204-A450-4A2438E0C573Q36332597-FF2ED33D-62E0-496D-BF34-777DDBA31C3EQ36457273-37098411-B5F5-4FB8-87BC-ED5870EB5CCDQ36541051-FCD31664-4063-48D4-8634-98485EF4236CQ36809773-8F0EEAE1-0C90-40A5-9E23-A6A898A50375Q37108879-9C9014CD-5479-4CA3-B986-BD6531C7C433Q37281155-A5AAA98F-430A-4FBE-9092-FE89DCE1ABD0Q37347574-FD0765C9-9D2D-45F6-AAE7-C6244BEFDBA8Q37349852-39B47D5D-1966-4D87-B00A-BD7E647368CBQ38126091-4F0B21D3-FA15-40F3-8268-D82C3728CC7EQ38189135-2E9743B9-107A-45E7-A31E-4FD001633AE9Q38241808-FB3EE0D7-FB97-4AE3-8A4B-67066C4DBAAAQ38366733-C33D46D5-A9C9-4B9B-B7DF-AF68EC2A9A7D
P2860
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association of depressive diso ...... medication with inflammation.
@ast
Association of depressive diso ...... medication with inflammation.
@en
type
label
Association of depressive diso ...... medication with inflammation.
@ast
Association of depressive diso ...... medication with inflammation.
@en
prefLabel
Association of depressive diso ...... medication with inflammation.
@ast
Association of depressive diso ...... medication with inflammation.
@en
P2093
P2860
P356
P1476
Association of depressive diso ...... medication with inflammation.
@en
P2093
A T F Beekman
B W J H Penninx
H E Duivis
J Neuteboom
N Vogelzangs
P de Jonge
W Hoogendijk
P2860
P2888
P356
10.1038/TP.2012.8
P577
2012-02-21T00:00:00Z